Publications:91
- Home
- Profiles
Video Visit Available
Accepting New Patients
Mount Sinai Doctors
Video Visit Available
Accepting New PatientsJohn M Oropello, MD
Critical Care
No Patient Experience Ratings
Physician Office
212-241-8867
- About Me
- Clinical Focus
- Education & Certifications
- Awards
- Research
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Adult Respiratory Distress Syndrome
- Bronchoscopy, Diagnostic
- Echocardiogram
- Intubation And Mechanical Ventilation
- Pneumonia
- Pulmonary Embolism
- Septic Shock
- Shock
- Adult Respiratory Distress Syndrome
- Bronchoscopy, Diagnostic
- Echocardiogram
- Intubation And Mechanical Ventilation
- Pneumonia
- Pulmonary Embolism
- Septic Shock
- Shock
Education
BA, Bernard Baruch College
MD, St. George's University School of Medicine
MD, St. George's University School of Medicine
, Coney Island Hospital
, Coney Island Hospital
, The Mount Sinai Hospital
Residency, Internal Medicine
Coney Island Hospital
Fellowship, Pulmonary Disease
Coney Island Hospital
Fellowship, Critical Care Medicine
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Awards
1990
Fellow-of-the-Year Award Critical Care Fellowship
The Mount Sinai Medical Center
1989
Consistent outstanding clinical performance during Internal Medicine Residency and Pulmonary Fellowship
Coney Island Hospital
1984
The Abdool Islami Award for Overall Academic Excellence
St. Georges' University, Grenada
1978
The President's Excellency Award for the
Baruch College Honors Program, New York
1978
The Muriel Lee Winokur Biology Scholarship
1978
Magna Cum Laude with Honors in Biology
Bernard Baruch College, New York, NY
Research
Research Projects Current:
\r\n\r\nKohli-Seth R, Oropello JM, Benjamin E, Manasia A, Leibowitz A, DelGiudice R, Hufanda J. A double blind, placebo-controlled, study of E5564, a lipid A antagonist, administered by twice daily intravenous infusions in patients with severe sepsis. \r\n\r\n Benjamin E, Kohli-Seth R, Oropello JM, Leibowitz A, Manasia A, DelGiudice R, Hufanda J. Efficacy and safety of Drotrecogin (Alfa) in adult patients with early severe sepsis \r\n\r\n Oropello JM, Kohli-Seth R, Benjamin E, Manasia A, Leibowitz A, DelGiudice R, Hufanda J. Central venous access techniques: successful cannulation of central veins upon withdrawal of needle vs. advancement. \r\n\r\n Kohli-Seth R, Oropello JM, Benjamin E, Manasia A, Leibowitz A, DelGiudice R, Hufanda J. Resting energy expenditure in morbidly obese septic and non-septic patients \r\n\r\n Oropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. A Phase 2 study to determine the efficacy of Sivelestat in patients with Acute Lung Injury \r\n\r\n Benjamin E Kohli-Seth R, Oropello JM Manasia A, Hannon E, DelGiudice R, Hufanda J Benign postoperative hyperlactatemia in Neurosurgical Patients \r\n\r\n Benjamin E, Oropello JM, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Beginning and Ending Supportive therapy (BEST) for the Kidney Study \r\n Oropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Phase 3 multicenter randomized placebo study of PHP in sepsis with Shock. \r\n\r\n A Manasia, Benjamin E, Oropello JM, R. Kohli-Seth, R DelGiudice, J Hufanda. Limited transthoracic echocardiography (TTE) by non-cardiologist surgical intensivists. \r\n\r\n Oropello JM, Benjamin E, Manasia A, R. Kohli-Seth, R DelGiudice, J Hufanda.. J4A-MC-EZZI. A phase 2b Study to determine the efficacy and safety of LY315920 in patients with severe sepsis. \r\n\r\n S. Chhabra, Benjamin E, Oropello JM, Manasia A, Victor Murgolo, R DelGiudice, J Hufanda. Zeroing of hydraulic monitoring systems using laser guidance. \r\n\r\n Benjamin E, Oropello JM, Manasia A, Altschuller-Felberg C, Hufanda J, DelGiudice R: Multicenter, Double Blind, Placebo Controlled, Randomized, Phase III Study of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor [rTFPA/SC-59735]) in Severe Sepsis. \r\n\r\n Benjamin E Oropello JM. Nierman D, Loren S, Hufanda J, DelGiudice R. Prospective study of anemia of critical illness and transfusion is critically ill patients. \r\n\r\n Leibowitz A, Benjamin E, Oropello JM, Manasia, A, DelGiudice R., A randomized, open-labeled, pilot assessment of the effect of Protonix IV for injection (Pantoprazole Sodium) on gastric pH in ICU patients. \r\n\r\n Oropello JM, Benjamin E, Altschuller-Felberg C, DelGiudice R, Hufanda J. . Open-label, comparative, randomized multicenter Phase 111 study of iv Synercid vs.Vancomycin or Nafcillin in the treatment of 380 patients with central venous catheter-related bacteremia. \r\n\r\n Manasia A, Oropello JM, Benjamin E, Altschuller-Felberg C, DelGiudice R A Phase II, Dose-Ranging Evaluation of Safety and Efficacy of a-hANP for ARDS. \r\n\r\n Kohli-Seth, Benjamin E. Oropello JM, Manasia, DelGiudice R, Hufanda J Amede F. The effect of continuous veno-venous hemofiltration (CVVH) on lung water as measured by transthoracic impedance analysis (TBIA). \r\n\r\n Oropello JM, Altschuller-Felberg C, Benjamin E, Manasia A, DelGuidice R: rSP-c surfactant for the treatment of acute respiratory distress syndrome (ARDS), a randomized, multicenter, parallel group, controlled pilot study. \r\n\r\n Oropello JM, Manasia A, Benjamin E, Altschuller-Felberg C, DelGuidice R: A phase II study to determine the efficacy and safety of LY315920 in patients with severe sepsis. \r\n \r\n Benjamin E, Oropello JM, Manasia A, Altschuller-Felberg C Hufanda, J: Multicenter, single blind, placebo-controlled, randomized, dose escalation study of recombinant tissue factor pathway inhibitor (rTFOI/SC-59735) in severe sepsis. \r\n
\r\n\r\n
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
- Physician Office1468 Madison Avenue, 6th Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Cigna - Medicare
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Hotel Trades
- Humana Medicare
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- NJ Medicaid
- NY Medicaid
- Oscar
- Partners Health Plan
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- The association between integrating echocardiography use in the management of septic shock patients and outcomes in the intensive care unit: a systematic review and meta-analysis. Keith Killu, Cecilia Patino-Sutton, Lynn Kysh, Richard Castriotta, John Oropello, Luis Huerta, Dominic Engracia, Karim Merchant, Choo Phei Wee, Victoria Kristence Cortessis. Journal of Ultrasound
- Ultrasound-guided Axillary Artery Catheter Placement and Associated Complications in Critically Ill Patients. Stephanie Cardona, Aliza S. Gross, Allen T. Yu, Adel Bassily-Marcus, John Oropello, Anthony Manasia. Journal of Intensive Care Medicine
- The authors reply. Joseph L. Nates, Stephen M. Pastores, John M. Oropello. Critical Care Medicine
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Oropello during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Association of Pulmonary and Critical Care Program Directors
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Oropello during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Association of Pulmonary and Critical Care Program Directors
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.